 article may be found online at www.jvascsurg.org.
Correspondence: M. Hassan Murad, MD, MPH, Mayo Clinic, Division of Preventive, Occupational and Aerospace Medicine, 200 1st St SW, Rochester, MN
55905 (e-mail: murad.mohammad@mayo.edu).

99S

100S

Journal of Vascular Surgery

Hasan et al

January Supplement 2022

Table. Research questions
Patient

Intervention

Comparison

Outcomes

Study design

Subgroups

Question 1. What is the comparative effectiveness of medical management vs carotid intervention in asymptomatic patients?
Asymptomatic
patients above
70% stenosis

Medical
management

CEA or CAS

Stroke, ipsilateral
stroke, death
(or mortality),
MI, combined

RCTs or
observational

30 day, >30 day,
5 years or more

Question 2. What is the comparative effectiveness of carotid endarterectomy vs carotid artery stenting in symptomatic patients?
Symptomatic
patients

CEA

CAS

Stroke, ipsilateral
stroke, death
(or mortality), MI

RCTs

30 day, >30 day,
5 years or more

Question 3. What is the optimal timing of carotid intervention after acute stroke?
Patients with acute
stroke with >50%
carotid stenosis

Intervention
(CEA or CAS)
<2 days

Intervention
2-14 days,
>14 days

RCT or
Improvement,
observational
deterioration,
death (perioperative,
30 days) cerebral
hem or hyperperfusion,
MI, new stroke

CEA, CAS

Question 4. Which high-risk patients should be screened for carotid disease?
Screening carotid No
Patients with risk
duplex/Doppler
screening
factors for atherosclerosis
(ie, HTN, smokers,
hypercholesterolemia,
PAD, CAD, DM,
RF)

Prevalence of
>50% stenosis,
mortality, stroke

Any (comparative
Risk factors
or noncomparative)

Question 5. In patients with combined coronary/carotid disease, what is the optimal sequence for intervention